Logo image of PRZO

PARAZERO TECHNOLOGIES LTD (PRZO) Stock Fundamental Analysis

NASDAQ:PRZO - Nasdaq - IL0011857013 - Common Stock - Currency: USD

1.4  +0.23 (+19.66%)

After market: 1.4 0 (0%)

Fundamental Rating

2

Overall PRZO gets a fundamental rating of 2 out of 10. We evaluated PRZO against 125 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of PRZO have multiple concerns. PRZO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PRZO has reported negative net income.
In the past year PRZO has reported a negative cash flow from operations.
PRZO had negative earnings in each of the past 5 years.
In the past 5 years PRZO always reported negative operating cash flow.
PRZO Yearly Net Income VS EBIT VS OCF VS FCFPRZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

PRZO has a worse Return On Assets (-227.98%) than 99.20% of its industry peers.
Industry RankSector Rank
ROA -227.98%
ROE N/A
ROIC N/A
ROA(3y)-126.97%
ROA(5y)-150.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PRZO Yearly ROA, ROE, ROICPRZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

Looking at the Gross Margin, with a value of 10.82%, PRZO is doing worse than 76.80% of the companies in the same industry.
In the last couple of years the Gross Margin of PRZO has declined.
PRZO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.26%
GM growth 5YN/A
PRZO Yearly Profit, Operating, Gross MarginsPRZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

3

2. Health

2.1 Basic Checks

PRZO does not have a ROIC to compare to the WACC, probably because it is not profitable.
PRZO has more shares outstanding than it did 1 year ago.
There is no outstanding debt for PRZO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRZO Yearly Shares OutstandingPRZO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
PRZO Yearly Total Debt VS Total AssetsPRZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -8.36, we must say that PRZO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -8.36, PRZO is not doing good in the industry: 93.60% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.36
ROIC/WACCN/A
WACC9.02%
PRZO Yearly LT Debt VS Equity VS FCFPRZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

A Current Ratio of 3.87 indicates that PRZO has no problem at all paying its short term obligations.
PRZO has a better Current ratio (3.87) than 73.60% of its industry peers.
PRZO has a Quick Ratio of 3.57. This indicates that PRZO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PRZO (3.57) is better than 79.20% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 3.57
PRZO Yearly Current Assets VS Current LiabilitesPRZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for PRZO have decreased strongly by -28.80% in the last year.
PRZO shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.23%.
Measured over the past years, PRZO shows a quite strong growth in Revenue. The Revenue has been growing by 8.99% on average per year.
EPS 1Y (TTM)-28.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)50.23%
Revenue growth 3Y8.99%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRZO Yearly Revenue VS EstimatesPRZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 200K 400K 600K 800K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRZO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRZO Price Earnings VS Forward Price EarningsPRZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRZO Per share dataPRZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PRZO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARAZERO TECHNOLOGIES LTD

NASDAQ:PRZO (6/13/2025, 8:00:01 PM)

After market: 1.4 0 (0%)

1.4

+0.23 (+19.66%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.06%
Inst Owner ChangeN/A
Ins Owners0.3%
Ins Owner ChangeN/A
Market Cap23.35M
AnalystsN/A
Price TargetN/A
Short Float %5.83%
Short Ratio1.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.22
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.07
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -227.98%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.82%
FCFM N/A
ROA(3y)-126.97%
ROA(5y)-150.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.26%
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 353.95%
Cap/Sales 6.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.87
Quick Ratio 3.57
Altman-Z -8.36
F-Score3
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)184.94%
Cap/Depr(5y)120.97%
Cap/Sales(3y)4.87%
Cap/Sales(5y)3.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)50.23%
Revenue growth 3Y8.99%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-126.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-67.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.4%
OCF growth 3YN/A
OCF growth 5YN/A